• Kaisa Health plans to rebrand as Qinghai Pharmaceutical Group, adopting the Chinese secondary name 青海製藥集團有限公司.
• The move follows its push into pharmaceuticals via a proposed acquisition tied to Qinghai Pharmaceutical Co., a healthcare business with more than 60 years of history.
• Trading short names on the Hong Kong exchange are set to change, subject to exchange confirmation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Health Group Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12245421), on July 15, 2026, and is solely responsible for the information contained therein.